Clinical Trial Update: Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus

View source ↗

Summary

Post-marketing surveillance of Alesion in Japanese pediatric patients with allergic rhinitis, atopic dermatitis (eczema/dermatitis), urticaria, and pruritus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Atopic Dermatitis
• Pruritus
• Urticaria

Drugs mentioned

• Alesion

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Rhinitis, Allergic, Perennial | Status: COMPLETED